Dermatophytic Onychomycosis Market By Therapy Type and End User - Global Industry Analysis & Forecast to 2027

Published On : October 2018 Pages : 180 Category: Pharmaceuticals Report Code : HC101506

Request Sample Inquiry Before Buying Request for Customization Check Discount

Dermatophytic Onychomycosis Market By Therapy Type (Topical Therapy, Systemic Therapy and Device-based Therapy), End User (Dermatology Clinics, Hospitals and Retail Pharmacies) - Global Industry Analysis & Forecast to 2027

Industry Outlook and Trend Analysis

The Dermatophytic Onychomycosis Market has encountered significant development over the recent years and is anticipated to grow tremendously over the forecast period. Nail onychomycosis is caused by a parasite called Trichophyton mentagrophytes and Trichophyton rubrum. Nonetheless, some cases may likewise be caused by yeasts and molds. Organisms develop and spread because of states of moisture and warmth. The contamination starts as a white or yellow spot under the tip of the nail and as it spreads further into the nail, it causes conceivably agonizing nail staining, thickening, and growth of disintegrating edges.

Drivers and Restraints

The main driver for development of the dermatophytic onychomycosis treatment market is high pervasiveness of dermatophytic onychomycosis around the world. As per a report published in 2017 in the Journal of the European Academy of Dermatology and Venereology, the main predominance of dermatophytic onychomycosis in Europe and North America was 4.3% in the populace based examinations and 8.9% in the healing center based examinations, thereby boosting the requirement of the treatment. Moreover, expanding geriatric populace over the globe is another main consideration driving development of the market.

Regional Insights

Marketing campaigns by the established brands in Asia Pacific are anticipated to rise in the coming years, in turn, increasing consumer awareness regarding the condition in the region.

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
South America
- Brazil
- Argentina
- Columbia
- Rest of South America
Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA

Competitive Analysis

The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.

Topica Pharmaceuticals, Inc
Allergen, Inc
Novartis
Anacor Pharmaceuticals Inc.
GlaxoSmithKline
Pfizer
Johnson & Johnson
Celtic Pharma
Moberg Pharma
Bayer
Galderma
Bausch Health
Sanofi

Some of the key questions answered by the report are:

What was the market size in 2017 and forecast from 2017 to 2027?
What will be the industry market growth from 2017 to 2027?
What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
What are the major segments leading the market growth and why?
Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?

Market Classification

· Dermatophytic Onychomycosis Market, By Therapy Type, Estimates and Forecast, 2017-2027 ($Million)

· Systemic Therapy

· Topical Therapy

· Device-based Therapy

· Dermatophytic Onychomycosis Market, By End User, Estimates and Forecast, 2017-2027 ($Million)

· Dermatology Clinics

· Hospitals

· Retail Pharmacies

· Dermatophytic Onychomycosis Market, By Region, Estimates and Forecast, 2017-2027 ($Million)

· North America

§ North America Dermatophytic Onychomycosis Market, By Country

o U.S. Dermatophytic Onychomycosis Market

o Canada Dermatophytic Onychomycosis Market

o Mexico Dermatophytic Onychomycosis Market

· Europe

§ Europe Dermatophytic Onychomycosis Market, By Country

o Germany Dermatophytic Onychomycosis Market

o UK Dermatophytic Onychomycosis Market

o France Dermatophytic Onychomycosis Market

o Russia Dermatophytic Onychomycosis Market

o Italy Dermatophytic Onychomycosis Market

o Rest of Europe Dermatophytic Onychomycosis Market

· Asia-Pacific

§ Asia-Pacific Dermatophytic Onychomycosis Market, By Country

o China Dermatophytic Onychomycosis Market

o Japan Dermatophytic Onychomycosis Market

o South Korea Dermatophytic Onychomycosis Market

o India Dermatophytic Onychomycosis Market

o Southeast Asia Dermatophytic Onychomycosis Market

o Rest of Asia-Pacific Dermatophytic Onychomycosis Market

· South America

§ South America Dermatophytic Onychomycosis Market

o Brazil Dermatophytic Onychomycosis Market

o Argentina Dermatophytic Onychomycosis Market

o Columbia Dermatophytic Onychomycosis Market

o Rest of South America Dermatophytic Onychomycosis Market

· Middle East and Africa

§ Middle East and Africa Dermatophytic Onychomycosis Market

o Saudi Arabia Dermatophytic Onychomycosis Market

o UAE Dermatophytic Onychomycosis Market

o Egypt Dermatophytic Onychomycosis Market

o Nigeria Dermatophytic Onychomycosis Market

o South Africa Dermatophytic Onychomycosis Market

o Rest of MEA Dermatophytic Onychomycosis Market

Table of Contents:

1. Introduction

1.1. Report Description

2. Executive Summary

2.1. Key Highlights

3. Market Overview

3.1. Introduction

3.1.1. Market Definition

3.1.2. Market Segmentation

3.2. Market Dynamics

3.2.1. Drivers

3.2.2. Restraints

3.2.3. Opportunities

3.3. SWOT Analysis

4. Market Analysis by Regions

4.1. North America (United States, Canada and Mexico)

4.1.1. United States Market Status and Outlook (2017-2027)

4.1.2. Canada Market Status and Outlook (2017-2027)

4.1.3. Mexico Market Status and Outlook (2017-2027)

4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

4.2.1. Germany Market Status and Outlook (2017-2027)

4.2.2. France Market Status and Outlook (2017-2027)

4.2.3. UK Market Status and Outlook (2017-2027)

4.2.4. Russia Market Status and Outlook (2017-2027)

4.2.5. Italy Market Status and Outlook (2017-2027)

4.2.6. Rest of Europe Market Status and Outlook (2017-2027)

4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)

4.3.1. China Market Status and Outlook (2017-2027)

4.3.2. Japan Market Status and Outlook (2017-2027)

4.3.3. Korea Market Status and Outlook (2017-2027)

4.3.4. India Market Status and Outlook (2017-2027)

4.3.5. Southeast Asia Market Status and Outlook (2017-2027)

4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)

4.4. South America (Brazil, Argentina, Columbia and Rest of South America)

4.4.1. Brazil Market Status and Outlook (2017-2027)

4.4.2. Argentina Market Status and Outlook (2017-2027)

4.4.3. Columbia Market Status and Outlook (2017-2027)

4.4.4. Rest of South America Market Status and Outlook (2017-2027)

4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)

4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)

4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)

4.5.3. Egypt Market Status and Outlook (2017-2027)

4.5.4. Nigeria Market Status and Outlook (2017-2027)

4.5.5. South Africa Market Status and Outlook (2017-2027)

4.5.6. Turkey Market Status and Outlook (2017-2027)

4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)

5. Dermatophytic Onychomycosis Market, By Therapy Type

5.1. Introduction

5.2. Global Dermatophytic Onychomycosis Revenue and Market Share by Therapy Type (2017-2027)

5.2.1. Global Dermatophytic Onychomycosis Revenue and Revenue Share by Therapy Type (2017-2027)

5.3. Topical Therapy

5.3.1. Global Topical Therapy Revenue and Growth Rate (2017-2027)

5.4. Systemic Therapy

5.4.1. Global Systemic Therapy Revenue and Growth Rate (2017-2027)

5.5. Device-based Therapy

5.5.1. Global Device-based Therapy Revenue and Growth Rate (2017-2027)

6. Dermatophytic Onychomycosis Market, By End User

6.1. Introduction

6.2. Global Dermatophytic Onychomycosis Revenue and Market Share by End User (2017-2027)

6.2.1. Global Dermatophytic Onychomycosis Revenue and Revenue Share by End User (2017-2027)

6.3. Dermatology Clinics

6.3.1. Global Dermatology Clinics Revenue and Growth Rate (2017-2027)

6.4. Hospitals

6.4.1. Global Hospitals Revenue and Growth Rate (2017-2027)

6.5. Retail Pharmacies

6.5.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)

7. Dermatophytic Onychomycosis Market, By Region

7.1. Introduction

7.2. Global Dermatophytic Onychomycosis Revenue and Market Share by Regions

7.2.1. Global Dermatophytic Onychomycosis Revenue by Regions (2017-2027)

7.3. North America Dermatophytic Onychomycosis by Countries

7.3.1. North America Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2027)

7.3.2. North America Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2027)

7.3.3. United States

7.3.3.1. United States Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.4. Canada

7.3.4.1. Canada Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.3.5. Mexico

7.3.5.1. Mexico Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4. Europe Dermatophytic Onychomycosis by Countries

7.4.1. Europe Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2027)

7.4.2. Europe Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2027)

7.4.3. Germany

7.4.3.1. Germany Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.4. France

7.4.4.1. France Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.5. UK

7.4.5.1. UK Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.6. Russia

7.4.6.1. Russia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.7. Italy

7.4.7.1. Italy Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.4.8. Rest of Europe

7.4.8.1. Rest of Europe Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5. Asia-Pacific Dermatophytic Onychomycosis by Countries

7.5.1. Asia-Pacific Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2027)

7.5.2. Asia-Pacific Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2027)

7.5.3. China

7.5.3.1. China Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.4. Japan

7.5.4.1. Japan Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.5. Korea

7.5.5.1. Korea Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.6. India

7.5.6.1. India Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.7. Southeast Asia

7.5.7.1. Southeast Asia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.5.8. Rest of Asia-Pacific

7.5.8.1. Rest of Asia-Pacific Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6. South America Dermatophytic Onychomycosis by Countries

7.6.1. South America Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2027)

7.6.2. South America Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2027)

7.6.3. Brazil

7.6.3.1. Brazil Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.4. Argentina

7.6.4.1. Argentina Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.5. Columbia

7.6.5.1. Columbia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.6.6. Rest of South America

7.6.6.1. Rest of South America Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7. Middle East and Africa Dermatophytic Onychomycosis by Countries

7.7.1. Middle East and Africa Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2027)

7.7.2. Middle East and Africa Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2027)

7.7.3. Saudi Arabia

7.7.3.1. Saudi Arabia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.4. United Arab Emirates

7.7.4.1. United Arab Emirates Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.5. Egypt

7.7.5.1. Egypt Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.6. Nigeria

7.7.6.1. Nigeria Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.7. South Africa

7.7.7.1. South Africa Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.8. Turkey

7.7.8.1. Turkey Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

7.7.9. Rest of Middle East and Africa

7.7.9.1. Rest of Middle East and Africa Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

8. Company Profiles

8.1. Topica Pharmaceuticals, Inc

8.1.1. Business Overview

8.1.2. Service Portfolio

8.1.3. Strategic Developments

8.1.4. Revenue and Market Share

8.2. Allergen, Inc

8.2.1. Business Overview

8.2.2. Service Portfolio

8.2.3. Strategic Developments

8.2.4. Revenue and Market Share

8.3. Novartis

8.3.1. Business Overview

8.3.2. Service Portfolio

8.3.3. Strategic Developments

8.3.4. Revenue and Market Share

8.4. Anacor Pharmaceuticals Inc.

8.4.1. Business Overview

8.4.2. Service Portfolio

8.4.3. Strategic Developments

8.4.4. Revenue and Market Share

8.5. GlaxoSmithKline

8.5.1. Business Overview

8.5.2. Service Portfolio

8.5.3. Strategic Developments

8.5.4. Revenue and Market Share

8.6. Pfizer

8.6.1. Business Overview

8.6.2. Service Portfolio

8.6.3. Strategic Developments

8.6.4. Revenue and Market Share

8.7. Johnson & Johnson

8.7.1. Business Overview

8.7.2. Service Portfolio

8.7.3. Strategic Developments

8.7.4. Revenue and Market Share

8.8. Celtic Pharma

8.8.1. Business Overview

8.8.2. Service Portfolio

8.8.3. Strategic Developments

8.8.4. Revenue and Market Share

8.9. Moberg Pharma

8.9.1. Business Overview

8.9.2. Service Portfolio

8.9.3. Strategic Developments

8.9.4. Revenue and Market Share

8.10. Bayer

8.10.1. Business Overview

8.10.2. Service Portfolio

8.10.3. Strategic Developments

8.10.4. Revenue and Market Share

8.11. Galderma

8.11.1. Business Overview

8.11.2. Service Portfolio

8.11.3. Strategic Developments

8.11.4. Revenue and Market Share

8.12. Bausch Health

8.12.1. Business Overview

8.12.2. Service Portfolio

8.12.3. Strategic Developments

8.12.4. Revenue and Market Share

8.13. Sanofi

8.13.1. Business Overview

8.13.2. Service Portfolio

8.13.3. Strategic Developments

8.13.4. Revenue and Market Share

9. Global Dermatophytic Onychomycosis Market Competition, by Manufacturer

9.1. Global Dermatophytic Onychomycosis Revenue and Market Share by Manufacturer (2017-2017)

9.2. Global Dermatophytic Onychomycosis Price By Region (2017-2017)

9.3. Top 5 Dermatophytic Onychomycosis Manufacturer Market Share

9.4. Market Competition Trend

10. Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.1. Global Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2027)

10.2. Dermatophytic Onychomycosis Market Forecast by Regions (2017-2027)

10.2.1. North America Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.1.1. United States Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.1.2. Canada Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.1.3. Mexico Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2. Europe Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2.1. Germany Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2.2. France Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2.3. UK Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2.4. Russia Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2.5. Italy Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.2.6. Rest of Europe Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3. Asia-Pacific Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3.1. China Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3.2. Japan Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3.3. Korea Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3.4. India Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3.5. Southeast Asia Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.3.6. Rest of Asia-Pacific Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.4. South America Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.4.1. Brazil Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.4.2. Argentina Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.4.3. Columbia Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.4.4. Rest of South America Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5. Middle East and Africa Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.1. Saudi Arabia Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.2. United Arab Emirates Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.3. Egypt Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.4. Nigeria Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.5. South Africa Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.6. Turkey Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.2.5.7. Rest of Middle East and Africa Dermatophytic Onychomycosis Market Forecast (2017-2027)

10.3. Dermatophytic Onychomycosis Market Forecast by Therapy Type (2017-2027)

10.3.1. Dermatophytic Onychomycosis Forecast by Therapy Type (2017-2027)

10.3.2. Dermatophytic Onychomycosis Market Share Forecast by Therapy Type (2017-2027)

10.4. Dermatophytic Onychomycosis Market Forecast by End User (2017-2027)

10.4.1. Dermatophytic Onychomycosis Forecast by End User (2017-2027)

10.4.2. Dermatophytic Onychomycosis Market Share Forecast by End User (2017-2027)

List of Tables

List of Tables and Figures:

Figure United States Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Dermatophytic Onychomycosis Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Dermatophytic Onychomycosis Revenue and Revenue Share by Therapy Type (2017-2018)
Figure Global Topical Therapy Revenue and Growth Rate (2017-2018)
Figure Global Systemic Therapy Revenue and Growth Rate (2017-2018)
Figure Global Device-based Therapy Revenue and Growth Rate (2017-2018)
Table Global Dermatophytic Onychomycosis Revenue and Revenue Share by End User (2017-2018)
Figure Global Dermatology Clinics Revenue and Growth Rate (2017-2018)
Figure Global Hospitals Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Table Global Dermatophytic Onychomycosis Revenue by Regions (2017-2018)
Figure North America Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure North America Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2018)
Figure North America Dermatophytic Onychomycosis by Countries (2017-2018)
Figure North America Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2018)
Figure United States Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure United States Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Canada Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Mexico Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Europe Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2018)
Figure Europe Dermatophytic Onychomycosis by Countries (2017-2018)
Figure Europe Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2018)
Figure Germany Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Germany Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure France Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure UK Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Russia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Italy Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Rest of Europe Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Asia-Pacific Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Dermatophytic Onychomycosis by Countries (2017-2018)
Figure Asia-Pacific Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2018)
Figure China Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure China Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Japan Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Korea Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure India Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Southeast Asia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure South America Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2018)
Figure South America Dermatophytic Onychomycosis by Countries (2017-2018)
Figure South America Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Brazil Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Argentina Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Columbia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Rest of South America Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Middle East and Africa Dermatophytic Onychomycosis Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Dermatophytic Onychomycosis by Countries (2017-2018)
Figure Middle East and Africa Dermatophytic Onychomycosis Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Saudi Arabia Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure United Arab Emirates Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Egypt Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Nigeria Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure South Africa Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Turkey Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Dermatophytic Onychomycosis Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2017-2018)
Table Topica Pharmaceuticals, Inc Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Allergen, Inc Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Novartis Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Anacor Pharmaceuticals Inc. Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table GlaxoSmithKline Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Pfizer Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Johnson & Johnson Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Celtic Pharma Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Moberg Pharma Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bayer Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Galderma Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Bausch Health Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Table Sanofi Dermatophytic Onychomycosis Price, Revenue, Gross Margin and Market Share (2017-2017)
Figure Global Dermatophytic Onychomycosis Market Share by Manufacturer
Figure Global Dermatophytic Onychomycosis Revenue and Market Share by Manufacturer
Table Global Dermatophytic Onychomycosis Price by Region (2017-2017)
Figure Top 5 Dermatophytic Onychomycosis Manufacturer (Revenue) Market Share
Figure Market Competition Trend
Figure Global Dermatophytic Onychomycosis Revenue (Millions USD) and Growth Rate (2018-2025)
Table Dermatophytic Onychomycosis Market Forecast by Regions (2018-2025)
Figure North America Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure United States Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Canada Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Mexico Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Europe Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Germany Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure France Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure UK Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Russia Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Italy Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Rest of Europe Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Asia-Pacific Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure China Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Japan Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Korea Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure India Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Southeast Asia Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure South America Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Brazil Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Argentina Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Columbia Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Rest of South America Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Middle East and Africa Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Saudi Arabia Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure United Arab Emirates Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Egypt Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Nigeria Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure South Africa Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Turkey Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Dermatophytic Onychomycosis Market Forecast (2018-2025)
Figure Global Dermatophytic Onychomycosis Forecast by Therapy Type (2018-2025)
Figure Global Dermatophytic Onychomycosis Market Share Forecast by Therapy Type (2018-2025)
Figure Global Dermatophytic Onychomycosis Forecast by Therapy Type (2018-2025)
Figure Global Dermatophytic Onychomycosis Forecast by End User (2018-2025)
Figure Global Dermatophytic Onychomycosis Market Share Forecast by End User (2018-2025)
Figure Global Dermatophytic Onychomycosis Forecast by End User (2018-2025)

Please Note: Data related to the Companies are subject to Availability.

Research Methodology

We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.

Data Mining

Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.

Data Collection Matrix

Data Collection Matrix	Supply Side	Demand Side
Primary Data Sources	Manufacturers Distributors & Wholesalers GPOs	Physicians/Specialist Healthcare Providers Consumers
Secondary Data Sources	Annual Reports/SEC Filings/ Investor Presentations/ Press Releases Government/Associations Publications	Case Studies Reference Customers

Market Modeling and Forecasting

We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.

Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:

Number of patients for particular device or medical procedure and
Repeated use of particular device depending on health and condition of patient

Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.

We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.

Data Validation

We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.

Data Triangulation

data triangulation

Industry Analysis

Qualitative Data	Quantitative Data (2017-2025)
Market Dynamics (Drivers, Restraints, and Challenges) Industry Trend Analysis Market Opportunities Government Policies and Regulations, Patent Analysis, and Reimbursement Policies Porter’s Five Forces and PESTLE Analysis Key Developments and Competitive Landscape	Market Assessment and Forecast Market Assessment and Forecast, By Product Market Assessment and Forecast, By Technology Market Assessment and Forecast, By Application Market Assessment and Forecast, By End User Market Assessment and Forecast, By Region/Country

License Type

For Any Assistance

Name *

Email *

Country *

Phone number *

Message *